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Summary
In this study, we followed the genomic, lipidomic and
metabolomic changes associated with the selection
of miltefosine (MIL) resistance in two clinically
derived Leishmania donovani strains with different
inherent resistance to antimonial drugs (antimony
sensitive strain Sb-S; and antimony resistant Sb-R).
MIL-R was easily induced in both strains using the
promastigote-stage, but a significant increase in MIL-
R in the intracellular amastigote compared to the cor-
responding wild-type did not occur until promasti-
gotes had adapted to 12.2 lM MIL. A variety of
common and strain-specific genetic changes were
discovered in MIL-adapted parasites, including dele-
tions at the LdMT transporter gene, single-base
mutations and changes in somy. The most obvious
lipid changes in MIL-R promastigotes occurred to
phosphatidylcholines and lysophosphatidylcholines
and results indicate that the Kennedy pathway is
involved in MIL resistance. The inherent Sb resist-
ance of the parasite had an impact on the changes
that occurred in MIL-R parasites, with more genetic
changes occurring in Sb-R compared with Sb-S para-
sites. Initial interpretation of the changes identified in
this study does not support synergies with Sb-R in
the mechanisms of MIL resistance, though this
requires an enhanced understanding of the parasite’s
biochemical pathways and how they are genetically
regulated to be verified fully.
Introduction
Visceral leishmaniasis (VL, also called kala-azar) is a
neglected tropical disease responsible for at least
40,000 deaths/year, the majority of which occur in the
Indian sub-continent (ISC, Alvar et al., 2012). There are
a limited number of drugs available for chemotherapy of
VL and development of drug resistance limits their clini-
cal efficacy (Ready, 2014). Understanding the molecular
mechanisms responsible for drug resistance may allow
(i) the development of assays to predict the drug sus-
ceptibility of a clinical isolate, (ii) the design of interven-
tions to extend the clinical life of a drug, and (iii) the
guiding of R&D of new drugs.
First-line chemotherapy in the ISC has relied on pen-
tavalent antimonials since 1923 (among others, Sodium
Stibogluconate or Meglumine Antimoniate). Antimonials
have now been abandoned in the region because of
decreased clinical efficacy and high resistance rates of
the etiological agent, Leishmania donovani (Ready,
2014). Antimony-resistant (Sb-R) strains are still fre-
quently found in patients of the ISC, despite a lower
antimonial pressure in the region since its replacement
by miltefosine (MIL, hexadecylphosphocholine): this
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could be explained by the greater virulence of Sb-R par-
asites (Vanaerschot et al., 2014). Thus Sb-R parasites
are more likely to survive in the host and be transmitted
to a new host because they are more resistant to the
effectors of macrophages than Sb-S parasites (Carter
et al., 2005; Mukhopadhyay et al., 2011; Mukherjee
et al., 2013; Guha et al., 2014; Vanaerschot et al.,
2014). MIL was registered in India in 2002 and it is the
first oral drug for VL treatment. It is one of the main pil-
lars of the current kala-azar elimination programme that
aims to reduce the incidence of the disease in the ISC
to lower than one case per 10,000 individuals at district
or sub-district levels by 2015 (WHO-SEARO, 2011).
After 10 years of use, the efficacy of MIL is decreasing
in India (Sundar et al., 2012) and Nepal (Rijal et al.,
2013). Fully MIL-resistant (MIL-R) strains have not yet
been encountered in the ISC (Rijal et al., 2013; Praja-
pati et al., 2013) but this is probably only a matter of
time, as parasites with varying MIL susceptibilities have
been reported (Bhandari et al., 2012).
In the absence of MIL-R clinical isolates, the primary
way to study the mechanisms of resistance and to find
molecular markers is through experimental selection.
Previous reports showed that Leishmania rapidly develop
MIL resistance in experimental conditions (Perez-Victoria
et al., 2003) and that it was associated with a decreased
accumulation of the drug. Two mechanisms were
involved: (i) an increased drug efflux mediated by the
overexpression of an ATP-binding cassette (ABC) trans-
porter P-glycoprotein (LdBPK_341060, ABCB4), and (ii)
a decreased uptake through the inactivation of a P-type
ATPase, the MIL transporter LdMT (LdBPK_131590) and
its beta subunit LdRos3 (Perez-Victoria et al., 2006).
More recently, a series of high-throughput molecular
screening methods were applied to scrutinize adapta-
tions developed in selected MIL-R parasites. Genomic
analysis of MIL-R Leishmania major confirmed the impor-
tance of the P-type ATPase and identified mutations in
other genes (Coelho et al., 2012). In another study, RNA
microarray investigation detected many differentially
expressed genes in MIL-R L. donovani, highlighting a
compromised DNA replication/repair mechanism,
reduced protein synthesis and degradation, increased
drug efflux, altered energy utilization and increased anti-
oxidant defence mechanisms (Kulshrestha et al., 2014).
Finally, the metabolomic analysis of an Ethiopian MIL-R
L. donovani strain highlighted an increase in the levels of
amino acids, possibly to promote the adaptation of MIL-R
strains in the macrophage (Canuto et al., 2014).
Earlier work on MIL-resistance has focused on labora-
tory strains sampled from patients decades ago. This
does not take into account previous adaptations to other
drugs, in particular antimonials, which have exerted con-
tinuous selective pressure on natural populations of
L. donovani in the ISC since 1923 (Downing et al., 2011;
Decuypere et al., 2012). Consequently, we experimentally
selected MIL-resistance in an Sb-R and Sb-S L. donovani
strain recently derived from clinical isolates of Nepalese
patients. To comprehensively evaluate the underlying
mechanisms associated with resistance to MIL, we com-
pared the genome, metabolome and lipidome of wild-type
(WT) strains and lines gradually adapted to MIL.
Results
Genomic differences between WT Sb-S and Sb-R
strains prior to MIL exposure
High-depth genome sequence data allowed the identifi-
cation of key genomic differences between the two wild
type (WT, summarized in Table 1) L. donovani isolates
prior to adaption to MIL (further referred to as WT Sb-R
and WT Sb-S). Some of these were potentially associ-
ated with antimonial resistance in the Sb-R. Firstly, eight
changes in chromosome copy number distinguished the
pair: the WT Sb-R had a higher dose of chromosomes
2, 8, 11, 14 and 33 and a lower copy number of
Table 1. Summary of the genomic differences observed between Sb-S and Sb-R strains during the selection of MIL-resistance. Somy values
are rounded to the nearest unit.
Standing variation at outset Somya SNPsb CNVsc Indelsd
WT Sb-S vs WT Sb-R differences 8 127 16 51
Above affecting amino acids 33 13 33
Effect of MIL on above differences Yes in 5/8 none none None
New mutations during MIL-R Somya SNPse CNVsf Indels
Identical in Sb-S and Sb-Rg Lower chr13 none none None
At same gene in Sb-S and Sb-R A691P in Sb-S, E197D in Sb-R DLdMT in Sb-S None
Unique to Sb-S 2 1 homh1 17 het 8 (8 CDS) None
Unique to Sb-R 4 6 homi1 7 het 8 (298 CDS) None
For full data see Tables: aS2, bS3 and S4A, cS4B, dS4C, eS7 and S8, and fS10. gChr8 and chr33 also had reduced copy numbers. hA691P.
iIncludes E197D.
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chromosomes 5, 26 and 35 (Supporting Information
Table S2). Secondly, there were 127 SNPs between the
two isolates (Supporting Information Table S3), including
33 non-synonymous single-nucleotide polymorphisms
(SNPs, Supporting Information Table S4A), of which 10
were previously associated with Sb-R in the ISC (Down-
ing et al., 2011). Thirdly, 16 loci had a local copy num-
ber variation (CNV), affecting 30 genes and 3 non-
coding regions (Supporting Information Table S4B).
Fourthly, 38 deletions and 13 insertions differentiated
the pair, including a deletion in the WT Sb-R of two
bases at the AQP1 gene (aquaglyceroporin 1,
LdBPK_310030, Supporting Information Table S4C).
Differences in metabolite and lipid profile between WT
strains prior to MIL exposure
Approximately 350 metabolites were annotated with
IDEOM, 14 of them significantly different between the
two WT strains (summarized in Table 2, P-value<0.05).
These metabolites were associated with different meta-
bolic pathways including protein production, lipid metab-
olism and synthesis of DNA. Over 400 lipids were seen
in promastigote samples but only 21 were significantly
different between the two strains (P< 0.05, Supporting
Information Table S6). Sb-S WT promastigotes had sig-
nificantly higher levels of 10 phosphatidylcholines (PC)
and significantly higher levels of two lyso-PC (LPC) lip-
ids as peaks corresponding to LPC (19:0) and LPC
(24:0) were consistently identified in the Sb-S strain but
were absent in the Sb-R strain. The Sb-R WT strain had
significantly higher levels of eight PCs. All of the PCs
upregulated in the Sb-R strain were unsaturated, with
five or more c-c double bonds in the tail groups.
Exposure to MIL produces highly resistant L. donovani
parasites
Selection of WT promastigotes that were resistant to the
highest concentration of MIL tested (74 mM) took 31
weeks. Both WT strains took similar lengths of time to
adapt to the highest concentration of MIL. The suscepti-
bility of the MIL-R parasites was tested against the intra-
cellular amastigote stage using infected macrophages
throughout the experiment to determine if MIL-R selec-
tion at the promastigote stage was conveyed to the intra-
cellular amastigote stage. For both Sb-S and Sb-R
strains, the IC50 values of amastigotes did not increase
compared with the corresponding WT until promastigotes
Table 2. Summary of the metabolic and lipidomic differences observed between Sb-S and Sb-R strains during the selection of MIL-
resistance.
Standing variation at outset Metabolitesa LPCb PCb
WT Sb-S vs WT Sb-R differences 14 3 18
Effect of MIL on above differences N/A N/A 2 inc. In Sb-S MIL-R
New changes during MIL-R Metabolitesc LPCd PCe
Identical in Sb-S and Sb-R 8 0 0
Unique to Sb-S 15 4 11
Unique to Sb-R 4 5 10
For full data see Tables: aS5, bS6, cS11, dS12, eS13.
Table 3. The effect of MIL selection on the MIL IC50 values of
WT, MIL adapted parent and clones derived from the MIL-R parent
for Sb-S and Sb-R L. donovani strains.
Parasite
Mean IC50
value
(mM6SE) N
MIL-R/WT
IC50 ratio
Promastigotes
WT Sb-S 136 0.2 2
Sb-S MIL-R 74 mM parent 3716 15 2 28.1
Sb-S MIL-R 74 mM clone 2 1656 37 2 12.5
Sb-S MIL-R 74 mM clone 3 1646 1 2 12.4
Sb-S MIL-R 74 mM clone 6 1856 19 2 14.0
Sb-S MIL-R 74 lM clone 8 254 1 19.2
WT Sb-R 6.2 1
Sb-R MIL-R 74 mM parent 3576 3 2 57.9
Sb-R MIL-R 74 mM clone 3 2826 1 1 45.5
Sb-R MIL-R 74 mM clone 6 2816 1 1 45.8
Sb-R MIL-R 74 lM clone 9 2946 6 2 47.4
Intracellular amastigote
WT Sb-S 36 1 6
Sb-S MIL-R 3 mM 1 1 4.7
Sb-S MIL-R 6 mM 2 1 16.1
Sb-S MIL-R 12.2 mM 14 1 15.1
Sb-S MIL-R 49.2 mM 47 1 15.3
Sb-S MIL-R 74 mM parent 446 13 2
Sb-S MIL-R 74 mM clone 8 466 18 2
WT Sb-R 36 1 6
Sb-R MIL-R 3 mM 0.2 1 3.3
Sb-R MIL-R 6 mM 2 1 12.7
Sb-R MIL-R 12.2 mM 9 2 13.4
Sb-R MIL-R 49.2 mM 33 1 17.6
Sb-R MIL-R 74 mM parent 356 8 2 13.5
Sb-R MIL-R 74 mM clone 9 536 1 2
Sb-R MIL-R 74 mM clone 9 no drug 356 1 2
Clones in bold selected for detailed metabolomic/lipidomic analysis.
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tolerated 12.2 mM MIL (Table 3). The fully resistant pro-
mastigotes (74 mM) were also clearly resistant at the
amastigote stage, with an IC50 of 44 mM (15 times the
value of WT) and 35 mM (13 times the value of WT) for
the Sb-S MIL-R and Sb-R strain MIL-R, respectively,
(Table 3). Increasing the drug concentration to select
MIL-R promastigotes from 49.2 to 74 mM did not result in
a corresponding increase in the IC50 at the amastigote
stage (Table 3). The fact that Sb-S MIL-R and Sb-R MIL-
R parental promastigotes had IC50 values that were
higher than the maximum MIL concentration used to
induce resistance was not unexpected, as all two MIL-R
clones were grown in the medium containing 74 mM MIL.
An example of the data obtained is shown in Fig. 1A and
B (promastigotes of Sb-R and Sb-S strains) and Fig. 1C
(amastigotes of Sb-R strain).
The Sb-S MIL-R and Sb-R MIL-R promastigotes
adapted to 74 mM were then cloned to determine if the
clones had the same MIL susceptibility as the MIL-R par-
ent line. These clones had MIL IC50 values that were
lower than the corresponding MIL-R parent. This indicated
that selection resulted in a mixed population of parasites
with different susceptibilities to MIL (Table 2). The clones
with the highest resistance to MIL for both strains (clone 8
for the Sb-S MIL-R strain, clone 9 for the Sb-R MIL-R
strain) were then tested for their susceptibility to MIL as
intramacrophage amastigotes using in vitro infected mac-
rophages. The IC50 value of the Sb-S MIL-R parent and
its clone were similar, and removal of MIL pressure for 2
weeks of culture did not alter the MIL susceptibility of the
MIL Sb-S MIL-R cloned parasite. In contrast, the cloned
Sb-R MIL-R parasite had a slightly higher IC50 compared
to its parent, and culturing the cloned parasite in the
absence of MIL resulted in a drop in MIL susceptibility of
the cloned parasite to the Sb-R MIL-R parent range.
Selection of MIL-R did not impact on Sb susceptibility as
the Sb-R MIL-R clone 9 gave a similar dose-response to
SSG treatment as the WT Sb-R parasite (Fig. 1D).
Fig. 1. The effect of drug treatment on the survival of promastigotes (A, B) or intracellular amastigotes (C, D) of L. donovani parasites
treated with MIL (A, B, C) or sodium stibogluconate (SSG, D). Promastigotes of the Sb-S or Sb-S MIL-R clone 8 strain were grown in the
presence of medium alone (controls) or different concentrations of MIL (n56/treatment). Cytotoxicity was assessed by determining the mean
suppression of drug treated samples compared to the relevant control (A, B). In amastigotes studies, macrophages were infected with the
relevant parasite (C, Sb-R WT or Sb-R MIL-R clone 9, D; Sb-S WT or Sb-S MIL-R clone 8) and then incubated with medium alone (controls)
or medium containing MIL (C) or SSG (D, n54/treatment). After 72 hours, the percentage of cells infected was assessed and the mean
suppression in parasite numbers compared to the relevant control. Data is representative of a minimum of two experiments. *P< 0.05,
***P< 0.001 compared with relevant control.
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Genomic changes during MIL-R selection
The type of strain-specfic and common genetic changes
that occurred after MIL adaption of the two strains are
summarized in Table 1.
Mutated loci common to both strains. Upon selection of
MIL-R, the most significant change shared between the
Sb-S and Sb-R was of the LdMT locus on chr13
(LdBPK_131590, Supporting Information Tables S7-S8).
In addition to a decrease in the copy number of chr13
(Table 1, Fig. 2A and B), there were three different
mutations at this gene: one in the Sb-R and two in the
Sb-S. The Sb-R one (E197D) was observed at 35 mM
MIL and was present in all cells by that stage, despite
only emerging at 12.2 mM. Surprisingly, two independent
LdMT variants were discovered in the Sb-S MIL-R line:
a deletion (DLdMT) and a SNP (A691P); Figure 2B
shows the evolution of these variants during the selec-
tion process. At 3 mM, the 8.86 kb deletion of bases
621,000 to 629,860 encompassing two genes
(LdBPK_131590, the LdMT locus at positions 622,408-
625,701 and LdBPK_131600, at positions 627,613-
629,076) was found and it gradually increased in fre-
quency within the population from 7% (3 mM MIL) to
27% (6 mM) to 44% (12.2 mM) to 71% (35 mM). A691P
was first observed in the Sb-S parasite cell population
at 12.2 mM MIL with a frequency of 16%, indicating at
this stage 36% of the Sb-S population still survived with
the WT LdMT allele (apart from a reduced chr13 copy
number) assuming 10 generations/step. By 35 mM, only
2% of the Sb-S population did not have a mutant LdMT,
indicating that a WT LdMT was not viable at this level of
toxicity. The fall in population frequency of DLdMT from
71% (35 mM) to 33% (49 mM) and 29% (61 mM) was
paralleled by a corresponding jump in LdMT-A691P
(62% at 49 mM and 67% at 61 mM respectively). This
suggested that A691P was more advantageous at
higher concentrations of MIL than the deletion, perhaps
due to deleting an unannotated adjacent gene
(LdBPK_131600, at 627,613–629,076) or because some
unknown function of LdMT may be preserved by the
A691P substitution. Subsequent passaging in the
absence of drug pressure increased the frequency of
Fig. 2. The genetic mechanisms responsible for reducing the
amount of LdMT transporter protein in parasites.
A. Somy changes observed for Sb-R WT (top) and Sb-S WT
(bottom) during MIL exposure (x-axis) ranging from 0 (blue) to 74
mM (shades of red). The WT (0 uM) and fully resistant stages (74
mM) were completed with one and five replicates for Sb-R,
(respectively), and with three replicates for Sb-S. For Sb-R, a
resistant sample was passaged with (74174) and without the drug
(7410, with one replicate). For Sb-S, a resistant sample was
passaged without the drug too (7410). The blue-green-beige
shading indicates the ploidy state: 1 is disomic, 1.5 is trisomic, and
2 is tetrasomic. Chromosome 13 was downregulated in both
strains, Chr33 was only in the Sb-S one.
B. The routes to reducing LdMT dosage for Sb-S WT during MIL
exposure (x-axis) ranging from 0 to 74 mM: an initial decrease in
dose though aneuploidy at 3 mM, a deletion also at 3 mM, and then
A691P at 6 mM. The y-axis indicates the alleles’ copy number
within the Sb-S population assuming one LdMT copy represents
the expected disomic state. Black indicates the WT state (A691). At
3 mM MIL, the chromosome copy number decreased from 2.80 to
0.93, and a deletion occurred encompassing LdMT that continued
to increase in frequency until 35 mM. At 12 mM MIL, P691 occurred
and rose in level until the final step at 61 mM.
C. Localisation of the LdMT deletion in the Sb-R MIL-R strain;
upper part, sequencing read depth over the region; lower part,
physical map of the LdMT locus: coordinates were given in a draft
reference based on Pacbio sequencing, as this region contains
gaps in the current reference and was not properly assembled. The
two black arrows indicate the localization of the two 444 bp direct
repeats at the deletion boundaries.
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the deletion (DLdMT, 0.86) and the sensitive allele
(LdMT-A691; 0.04) relative to the resistant LdMT-P691
(0.10). Sequence alignments showed that the DLdMT
region adjoining LdBPK_131590 and LdBPK_131600
was flanked by two 444-bp direct repeats (Fig. 2C).
Changes in mutation frequencies over time during the
selection process were used to infer the relative impor-
tance of the different MIL-R mutations using a mathe-
matical model. The evolutionary history of mutations
already implicated in MIL-R indicated that mutations at
the LdMT gene were beneficial with a selective advant-
age of 17% for the deletion and 26% for the A691P
allele in Sb-S. No significant deviations from a neutral
model were observed for the other MIL-R mutations. Our
model predicted that the LdMT deletion was pre-existing
in the Sb-S cell population at a frequency of close to 1%
(Supporting Information Fig. S1). By contrast, A691P
was inferred to have a frequency< 0.02% in the initial
population, suggesting that this could be a de novo
mutation. Changes in copy number also appear to drive
adaptation to MIL (Supporting Information Table S9).
The deletion of LdMT was verified by PCR using
genomic DNA prepared from Sb-S MIL-R clone 8 and
Sb-R MIL-R clone 9 promastigotes, and a PCR product
was only detected with the latter (data not shown).
LdMT expression was verified in WT Sb-R and Sb-R
MIL-R promastigotes by quantitative RT-PCR. LdMT
transcripts were present in the WT Sb-R but not in the
Sb-R MIL-R clone 9, while both samples showed alpha
tubulin transcripts (Ct values for WT Sb-R, Sb-R MIL-R
and negative controls, respectively; (i) for alpha-tubulin:
24.0760.28; 27.196 0.84; 35.0160.94 and (ii) for
LdMT: 27.376 0.36;> 35. We verified in the Illumina
alignments if SNPs were present in the UTRs flanking
LdBPK_131590 and did not find any: the next SNP was
a synonymous C/A transition at position 575518 of gene
LdBPK_131610 (position corresponds to new draft refer-
ence genome after PacBio sequencing, unpublished
data; it corresponds to position 631021 in the current
reference genome).
MIL-selected changes specific to different backgrounds. All
the genomic differences observed at the onset of the study
between the WT Sb-S and Sb-R strains remained upon
MIL-R selection, except the somy of 5 chromosomes (2, 8,
14, 33 and 35, summarized in Table 1). For each sample,
a series of specific variants appeared during the selection
(Supporting Information Text S1 and S2). When comparing
the Sb-S MIL-R strain to its WT counterpart, somy was
altered in 4 chromosomes (increase of Chr6, 14 and 23
and decrease of Chr33, Supporting Information Table S2),
there were 17 heterozygous SNPs (Supporting Information
Table S7) and 10 CNVs (Supporting Information Table
S10) – the sole homozygous SNP was A691P. For the Sb-
R MIL-R versus WT comparison, somy was also altered
for 4 chromosomes (decrease in Chr2 and 8, increase in
Chr9 and 35, Supporting Information Table S2), there were
6 homozygous SNPs (including E197D), 7 heterozygous
ones (Supporting Information Table S8), and 10 CNVs
(Supporting Information Table S10). Interestingly, all CNVs
observed in the Sb-S MIL-R strain corresponded to single
CDS, while 4 of the CNVs of the Sb-R MIL-R strain corre-
sponded to large fragments of chromosomes (amplification
of 49,735 bp in Chr27, spanning a whole transcription unit;
deletion of 116,778 bp in Chr 31; two deletions of 307,617
bp and 674,372 bp, respectively, in Chr35) containing a
total of 298 CDS (Tables 1 and Supporting Information
Table S10).
MIL transporter mutations are likely to prevent
phospholipid transport
A variety of mechanisms could be responsible for the
higher resistance of MIL-adapted parasites compared
with the corresponding WT. One is reduced drug uptake
by the MIL adapted parasites compared to the WT. To
explore this, we initially monitored MIL levels in Sb-R
WT and Sb-R MIL promastigotes exposed to MIL. We
found that it was only possible to determine drug levels
up to two hours post-treatment as WT parasites began
to show signs of cell death after two hours, resulting in
smaller number of parasites being present. We then
compared MIL levels in drug exposed Sb-S WT and Sb-
R WT promastigotes and their MIL resistant parasites.
MIL concentrations were significantly lower in the MIL-R
promastigotes compared to the corresponding WT para-
sites (P<0.05) at all times points, indicating that MIL
uptake was minimal or even non-existent in MIL-R para-
sites (Fig. 3).
Metabolomic changes during MIL-R selection
Twenty-three metabolites were significantly altered in
the Sb-S MIL-R clone compared with the Sb-S WT par-
ent and in all cases adaptation to MIL was associated
with an up regulation in the metabolites (P< 0.05,
Tables 2 and Supporting Information S11). In contrast
only 12 metabolites were significantly different in Sb-R
MIL-R clone compared with the Sb-R WT, with 9 being
upregulated and 3 being down regulated compared to
the WT (Supporting Information Table S11). Inspection
of the metabolites altered in the Sb-S and Sb-R strains
(Supporting Information Table S5) and their correspond-
ing MIL adapted strains (Supporting Information Table
S11) indicates that differences in the metabolites was
not simply due to existing differences in the metabolites
present in the WT strains.
Characterisation of MIL-R Leishmania donovani parasites 1139
VC 2015 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 99, 1134–1148
Nine metabolites involved in lipid metabolism were
found to be the affected by selection of MIL resistance
between the two strains. Six of these are involved in the
Kennedy pathway (Fig. 4), the primary metabolic path-
way for the synthesis of PC and phosphatidylethanol-
amines (PE). Only three of the significantly altered
metabolites were common to both MIL-R clones, that is,
choline-phosphate, phosphodimethylethanolamine (both
involved in the Kennedy pathway) and stearoylglycerone
phosphate, and they were all upregulated.
Lipidomic changes during the MIL-R selection
Selection of MIL-R was associated with significant differ-
ences in lipid content compared to the corresponding
WT parent but these were restricted to PC and LPC lip-
ids (summarized in Table 2), and alterations in the com-
position of PE lipids (data not shown). Four LPCs were
significantly upregulated in the Sb-S MIL-R strain com-
pared to its WT. Three LPCs were upregulated in the
Sb-R MIL-R strain compared to its WT, and two were
down regulated (Supporting Information Table S13). Two
of these altered LPCs were common to both MIL-R
strains [LPC(16:00) and LPC(18:0)], and in both cases
the corresponding LPC was upregulated compared to
the respective WT.
Eleven PCs were found in significantly higher amounts
between the Sb-S MIL-R strain and its WT, with six hav-
ing a ratio of> 2.0. In sharp contrast, all 10 PC were
downregulated in the Sb-R MIL-R strain compared with
its WT (Table S13). None of the altered PCs were com-
mon to the two MIL-R strains (Table S13). Only five PCs
altered in the MIL-R strains were significantly different
between the two WT strains (compare Supporting Infor-
mation Tables S6 and S13). Three PCs were signifi-
cantly higher in the WT Sb-S strain compared to the
WT Sb-R strain [PC(32:0), PC(33:0), PC(35:0)] and
MIL-R selection further increased this difference. All of
the PCs found to differ between Sb-S MIL-R and WT
were downregulated, long chain PCs and highly unsatu-
rated (at least 39 carbons in the side chains and 4 to 10
carbon double bonds). In contrast, all PCs significantly
different in Sb-R MIL-R were upregulated and were
either saturated or had only a small number of carbon
double bonds (maximum of 4).
Phosphodimethylethanolamines (PEs), diacyl-glycerols
(DAGs), triacyl-glycerols (TAGs), sphingolipids (SLs) and
other minor lipid classes were analyzed for alterations
occuring as a result of MIL-R. Of these, only SLs of Sb-R
MIL-R were found to differ significantly compared to the
corresponding WT. Of the sphingolipids identified in the
Sb-R WT and MIL-R lines, 15 were consistently downregu-
lated in the Sb-R MIL-R compared to Sb-R WT (P<0.05,
Supporting Information Table S14). Of these, eight were
different species of sphingomyelins and five were cer-
amides. Similar levels of these lipids were present in Sb-S
and Sb-R WTs, indicating that the significant changes in
these lipids were specific to the Sb-R MIL-R.
Discussion
We performed a stepwise selection of MIL resistance in
WT Sb-S (BPK282/0cl4) and Sb-R (BPK275/0cl18)
strains derived from recent clinical isolates from Nepal.
In the study, amastigote and promastigote MIL sensitiv-
ities together with lipidomic, metabolomic and genomic
changes possibly associated with MIL-resistance (MIL-
R) were assessed to explore a possible impact of Sb
susceptibility background on the development of MIL-R.
This study represents the first time such a comprehen-
sive biochemical and genomic screening has been
Fig. 3. A comparison of MIL uptake in MIL-R (Sb-S MIL-R clone 8, Sb-R MIL-R clone 9) and their corresponding WT strains (Sb-S and
Sb-R) of L. donovani. Promastigotes were cultured in HOMEM medium with and without 7 mM MIL for 0-120 min. Samples were quenched
and lipid extraction carried out using promastigotes samples (4 3 107, n54/treatment). The amount of MIL present (mg/ml) was determined
using a calibration curve prepared using MIL standards.
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performed, and it allowed molecular differences associ-
ated with adaptation to MIL to be linked to mutational
changes and changes in lipid and metabolite profile
within the two strains. In our study we focused our
molecular analyses on the promastigote stage rather
than the clinically relevant amastigotes, for several rea-
sons. It was impossible so far to select MIL-R in amasti-
gotes of L. donovani (Hendrickx et al., 2014); in
contrast, in promastigotes, it is rather easy and as dem-
onstrated here, the MIL-R phenotype is preserved in
derived amastigotes. In addition, it is difficult to extract
host-free amastigotes from in vitro or in vivo infected
macrophages and the purification and extraction proc-
esses may lead to changes in lipid or metabolite profiles
compared to what occurs in situ. Results from untar-
geted studies such as this study using promastigotes
can be used in the future to guide targeted studies in
amastigotes.
During the selection experiment, we generated paren-
tal lines with 28 to 57 times decreased susceptibility to
MIL as promastigotes, while decrease was around 13 to
15 times in the amastigote stages. A significant increase
in the IC50 value for the intramacrophage amastigote
stage was not apparent until parasites adapted to sur-
vive in 12.2 mM MIL. Studies on the pharmacokinetics of
MIL indicate that blood levels above this concentration
should be achieved, for example treatment with MIL at
100 mg/kg for 28 days resulted in maximal median con-
centration of 70 mg/ml (172 mM) on day 23 (Dorlo et al.,
2012). However blood levels may not be indicative of
MIL levels within the macrophage and more recent stud-
ies have indicated that MIL treatment failures are due to
limited drug exposure in patients (Dorlo et al., 2014)
rather than MIL-R in the parasite population. We
observed considerable cytotoxicity in macrophages
treated with 148 mM MIL, indicating that this concentra-
tion would be very cytotoxic if it is maintained in vivo
after dosing. Therefore intracellular levels are likely to
be much lower than 172 mM. Thus, intracellular para-
sites within the parasitophorous vacuole of infected
macrophages may have limited exposure to high con-
centrations of MIL, and this may explain why it has
proved difficult to show increased IC50 values in para-
sites recovered from patients that relapse after MIL
treatment (Rijal et al., 2013).
Clones derived from the parental MIL-R lines were
also resistant to the drug, albeit at variable degrees,
hereby supporting the polyclonal nature of a resistant
population with individual cells with varying susceptibil-
ities (Coelho et al., 2012). Our results also demon-
strated that the main mechanism responsible for the
resistance of our lines was a low accumulation of the
drug in MIL-R parasites. Previous studies showed that
this phenomenon can be associated with lower inflow of
higher efflux, through alterations of the P-type ATPase
LdMT and/or its beta sub-unit, LdRos3 (Perez-Victoria
et al., 2003; 2006) or over-expression of ABC-
transporters (Castanys-Mu~noz et al., 2008). From a
genomic point of view, our results converged on altera-
tions of LdMT in both Sb-S and Sb-R strains, and
no other miltefosine-driven changes were detected. Dif-
ferent types of mutations were observed, including
non-synonymous SNPs at different positions of LdMT,
complete deletion of the gene, and changes in the copy
number of chromosome 13 containing LdMT.
Fig. 4. Diagrammatic representation of the Kennedy pathway
metabolites altered in the MIL-R parasites of Sb-S (A) and Sb-R
(B) compared with their corresponding WT. A blue circle denotes a
significant down regulation (P< 0.05) of the metabolite in the MIL-R
strain compared to its WT. A red circle denotes a significant up
regulation (P< 0.05) in the MIL-R compared to WT. Key: a-chol,
acytelcholine; g-3-pchol, glycero-3-phosphocholine; chol, choline;
CDP-choline, cytidine diphosphate-choline; PC,
phosphatidylcholine; p-d-eth, phosphodimethylethanolamine; N-
meth-eth-p, N-methylethanolamine phosphate; eth, ethanolamine;
eth-p, ethanolamine phosphate; CDP-eth, cytidine diphosphate-
ethanolamine; PE, phosphodimethyethanolamine.
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Interestingly, the first genomic adaptation during selec-
tion was the early (< 12.2 mM MIL) shift of chromosome
13 from trisomy to disomy in both Sb-S and Sb-R.
Aneuploidy is a major feature of L. donovani genetic var-
iation (Downing et al., 2011; Mannaert et al., 2012) and
the ability to alter the chromosome copy number may
be a simple mechanism to respond quickly to selection
pressures, perhaps acting as transitional intermediate
fitness state until more beneficial mutations have
occurred (Covert et al., 2013).
Loss-of-function mutations are common in drug resist-
ant parasites (Ashley et al., 2014) and this loss of gene
function can offer a path to rapid adaptation to environ-
mental stresses (Khan et al., 2011). Deletion of LdMT
was observed in the Sb-S strain only with a changing
frequency during the selection process relative to alter-
native SNP alleles within the population of cells. LdMT
was deleted together with a gene encoding a hypotheti-
cal protein (LdBPK_131600) and deep analysis of the
sequence revealed that the locus containing the two
genes was flanked by two 444-bp direct repeats. Such
repeats are abundant in the Leishmania genome and by
homologous recombination they can lead to amplifica-
tion or deletion of the corresponding loci (Ubeda et al.,
2014). Mathematical modeling showed a selective
advantage for the deletion in the Sb-S strain, but the
advantage was higher for the A691P SNP. With respect
to SNPs, there is no evident pattern in the LdMT muta-
tions’ position on the protein internal or external portion,
effect on protein hydrophobicity, proximity to transmem-
brane (TM) domains (Supporting Information Tables
S15–17), or local domain type (Text S3). Last but not
least, we did not detect transcripts of LdMT in the Sb-R
MIL-R strain. This type of phenomenon is generally
associated with mutations in the regulatory regions
flanking the gene of interest and in present case, the
only SNP was within the CDS itself (E197D) and the
closest one was a C/A transition in the second next
gene (LdBPK_131610). Such a result is rather unex-
pected, but is similar to studies in trypanosomes where
a loss of heterozygocity at the TbAT1 locus accompa-
nied loss of expression (Stewart et al., 2010).
From a metabolomic point of view, a few metabolites
showed similar changes in both MIL-R strains. Three of
them were amino acids, class of metabolites previously
reported to be altered in different types of drug-resistant
L. donovani lines in which they were associated with pro-
tection against oxidative stress (Berg et al., 2013; 2015).
One of which was proline, which is also associated with
protection against oxidative stress (Inbar et al., 2013).
Another class of metabolites deserves particular attention,
that is, those involved in lipid metabolism. More specifi-
cally, the Kennedy pathway, the primary metabolic path-
way for the synthesis of PCs and PEs in L. donovani
(Kennedy and Weiss, 1956), appeared to be significantly
modulated upon resistance to MIL. While different metab-
olites of the Kennedy pathway were found to be modu-
lated in both MIL-R strains, two of them were common,
namely choline-phosphate and phosphodimethylethanol-
amine. Consistent with this finding, the lipid content of
MIL-R parasites was altered compared to their WT, with
PCs and LPCs being mostly affected. Four LPCs and 11
PCs were upregulated in Sb-S MIL-R compared to its WT,
and 8 of the PCs had between 1 and 4 double bonds in
the fatty acid tails. In contrast, most lipids were downregu-
lated in the Sb-R MIL-R compared with its WT, their PCs
were polyunsaturated and had relatively long chain tails.
This indicated that the antimony susceptibility background
of the strains did have an impact on the adaptation shown
by the parasites. Previous studies have highlighted an
altered lipid metabolism in MIL-R parasites and MIL treat-
ment has been associated with a decrease in PC content
in tandem with an increase in PE content. (Rakotomanga
et al., 2007; Imbert et al., 2012). This is somewhat corre-
lated with our Sb-R MIL-R clone in so far as a decrease
in PCs are observed. However a significant increase in
PC content was the most notable change in the lipid pool
for the Sb-S MIL-R. This inconsistency may reflect the dif-
ference in the genetic background of the parasites. Rako-
tomanga and Imbert’s studies used strain LV9 [MHOM/
LV9/HU3] from Ethiopia whereas clinical isolates from
Nepalese VL patients were used in this study. The compo-
sitions of lipids in the parasite membrane are known to
have a significant effect on the membrane fluidity (Berg
et al., 2013; 2015). Increasing the chain length or satura-
tion of fatty acid tails can also effect membrane fluidity
and increase resistance to oxidative stress, making the
parasites even better at tolerating exposure with reactive
oxygen species within the host macrophage (Zhang and
Beverly, 2010). Sphingolipid metabolism was also signifi-
cantly reduced in Sb-R MIL-R. Given that SLs are a major
source of ethanolamine phosphate in the Kennedy path-
way, it would be logical to see a knock on effect in the PE
content. While the total PE content of Sb-R MIL-R
appeared unaffected, the composition of the lipid anchors
altered with a significant increase in PEs with diacyl lipid
anchors. PEs can be synthesized via headgroup
exchange with PCs, and the significant decrease of
diacyl-PCs in Sb-R MIL-R compared to Sb-R WT could
be due to conversion of these PCs to PEs, which would
explain the reduction in SL metabolism in Sb-R MIL-R.
This study identified a number of genetic, lipidomic
and metabolomic changes during MIL adaptation in two
recent clinical isolates with differing prior sensitivities to
antimonials. Both isolate types adapted at similar rates
to MIL and could tolerate it at comparable levels. This
study highlighted that both shared a two-tiered genetic
response, first altering chromosome copy number and
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second mutating the LdMT gene when more MIL was
added. These changes were paralleled by metabolic
and lipid ones focused on the Kennedy pathway. More
metabolite changes occurred in the Sb-S strain com-
pared to the Sb-R one, suggesting that Sb-R was asso-
ciated with a faster development of MIL-R. However, the
picture was different from a genomic point of view, spe-
cifically at CNV level (298 in the Sb-R MIL-R strain vs 8
only in the Sb-S MIL-R one, Table 1). We found initial
evidence that antimonial resistance does not provide
immediate faster adaptations to high doses of MIL.
Future studies should address the lack of knowledge of
the biochemical pathways of Leishmania and their regu-
lation to improve understanding of the molecular mecha-
nisms responsible for MIL resistance. Our study focused
on two isolates but we have identified key metabolites,
lipids and genetic changes for future studies using more
strains. In addition supplementing the medium with
radiolabelled precursors (Millerioux et al., 2013) and
subsequent identification of metabolite/lipid products in
the Kennedy pathway, would allow more detailed analy-
sis of the impact of MIL-R on the parasite’s
biochemistry.
Experimental procedures
Materials
Miltefosine was kindly provided by WHO-TDR. Resazurin,
Giemsa stain, were purchased from Sigma-Aldrich (Gilling-
ham, UK). HOMEM medium (custom made by Invitrogen,
Paisley UK), RPMI-1640, penicillin/streptomycin, glycine
and foetal calf serum were obtained from Invitrogen, Pais-
ley, UK. All organic solvents (acetonitrile, isopropanol,
methanol, chloroform) were HPLC grade (Fisher Scientific,
Loughborough, UK). Ammonium formate was HPLC grade
(17843, Sigma-Aldrich Company, Gillingham, UK) and
mass spectroscopy vials (KVP6112) fitted with a low-
volume insert (INSF-01) were purchased from Kinesis(St
Neots, UK). Isolation of DNA and RNA was performed
using DNeasy Blood & Tissue kit or RNeasy Mini kit,
respectively, purchased from Qiagen, (Crawley, UK) and
cDNA synthesis was performed using AffinityScript Multiple
Temperature Reverse Transcriptase (Stratagene/Agilent
Technologies, Wokingham, UK). Random Primers (Bioline
Reagents, London, UK). MyTaq DNA polymerase reagents
(Bioline Reagents) were used for all standard PCR reac-
tions. Real Time PCR reactions were performed using
SYBRgreen Master Mix (Abgene/Thermo Scientific, Lough-
borough, UK).
Animals and parasites
Age matched inbred BALB/c female mice (20–25 g) in-
house bred were used in studies at Strathclyde University.
Animal studies were carried out with local ethical approval
and had UK Home Office approval. We used two clones
derived from Nepalese clinical isolates and previously
tested for their SSG susceptibility (Rijal et al., 2007):
MHOM/NP/03/BPK282/0cl4 (designated Sb-S, based on its
sensitivity to SbV and SbIII) and MHOM/NP/03/BPK275/
0cl18 (designated Sb-R, based on its relative insensitivity to
SbV and SbIII). Both parasites are representative of main
populations circulating in the ISC.
Selection of MIL resistant (MIL-R) clones
Selection was done on the promastigote stage: L. donovani
Sb-S and Sb-R strains were adapted to grow in increasing
concentrations in a step-wise manner with MIL (3, 6, 12.2,
35, 49.2, 61 mM and 74 mM) until all lines grew at similar
rates as wild-type parasites in HOMEM medium supple-
mented with 20% foetal calf serum. Promastigote resistance
to MIL was stopped at 74 mM because of toxicity for macro-
phages at higher concentrations. Clones derived from the
MIL-R lines were isolated using a micro-drop method (Van
Meirvenne et al., 1975), and expanded in Tobie’s medium
and then passaged using HOMEM medium supplemented
with 20% (v/v) foetal calf serum. A stock solution of aqueous
MIL (3 mg/ml, freshly prepared every 3 months) was stored
at 48C was used to prepare drug selection medium.
Lipidomic/metabolomic studies
Extraction of lipids or metabolites was carried out on day 4
of culture. Prior to extraction all of the biological replicate
cultures were quenched to 08C in an ethanol-dry ice bath to
halt metabolism. For each strain, four aliquots, from four
separate cultures, containing 4 3 107 promastigotes, were
pipetted into pre-chilled eppendorf tubes which were kept at
08C throughout the extraction procedure. The aliquots were
centrifuged for 3 min at 2,700 x g and the supernatant was
removed as spent medium for later analysis. The promasti-
gotes were then washed by re-suspending them in 1 ml of
PBS, pre-chilled to 08C. They were then centrifuged at
2,700 x g for 3 min and the supernatant was removed. This
washing procedure was repeated three times. After washing
the parasites were resuspended in 200 mL of methanol and
chloroform (1:1 v/v for lipid extraction) or chloroform:metha-
nol:water mixture (20:60:20 v/v for metabolite extraction)
and shaken in a thermomixer for 1 hour at 1400 rpm, 0oC.
The tubes were then centrifuged for 2,700 x g for 3 min at
08C and the resulting supernatant was removed and trans-
ferred to a mass spectrometry vial fitted with a low-volume
insert. Samples were stored at 2708C until analyzed.
Lipidomic and metabolomic samples were analyzed using
a Dionex Ultimate 3000 HPLC system (Thermo Fisher Sci-
entific Inc., Waltham, USA). A silica gel column (150mm x
3mm x 3mm, HiChrom, Reading, UK) was used for lipidomic
analysis and a ZIC-pHILIC column (150 mm 3 2.1 mm 3
5mm, Merck, Darmstadt, Germany) was used for metabolo-
mic analysis. The columns were connected to a Thermo
Scientific Exactive Mass Spectrometer (Thermo Fisher Sci-
entific Inc., Waltham, USA) running in positive/negative
scanning mode. In lipidomic analysis two solvents were
used in separation (solvent A: 20% isopropyl alcohol (IPA):
80% acetonitrile; solvent B: 20% IPA: 80% ammonium
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formate [20 mM]) using gradient elution at a flow of 0.3 ml/
min (0–1 min 8% B, 5 min 9% B, 10 min 20% B, 16 min
25% B, 23 min 35% B, 26–40 min 8% B). In metabolomic
studies different solvents were used in separation (solvent
A: 20mM ammonium carbonate adjusted to pH 9.2 with
ammonia; solvent B: 100% acetonitrile). Gradient elution at
a flow rate of 0.3 ml/min was used (0 min 80% B, 30 min
20% B, 31 min 8% B, 36 min 8% B, 37 min 80% B, 46 min
80% B). Processing of metabolite and lipid data was per-
formed as detailed in (t’Kindt et al., 2010). Briefly, raw data
files produced by the Exactive mass spectrometer were
converted to mxXML format and centroided using MSCon-
vert (Proteowizard, http://proteowizard.sourceforge.net/
downloads.shtml, accessed on 16 November 2014). Individ-
ual peaks were picked based on non-linear retention time
alignment, feature detection and feature alignment using
the centwave method from XCMS (https://metlin.scripps.
edu/xcms/). These peaks were converted to .peakML files
using MzMatch.R (http://mzmatch.sourceforge.net/index.
php). MzMatch.R was then used for peak extraction, filter-
ing, normalisation, group filtering and gap-filling of peaks.
This produced a single file in ‘.text ‘format containing peak
groups with the same mass/charge (m/z) values from the
different biological replicates. This file was then converted
to a .txt file and m/z values were identified as specific lipids
using Xcalibur and an in-house Excel macro that calculated
the total number of carbons and saturated carbon bonds in
the fatty acid tails of each lipid class. Metabolites were
identified using IDEOM (Creek Barrett, 2014) and 4 stand-
ard mixes were used in assays. The software identified
metabolites/lipids that were significantly different between
treatments. Comparisons between groups were based on
the ratio of WT/WT or MIL-R/WT, using the mean ratio for
the, respectively, WT used as comparator.
Genome sequencing and variant screening
Genomic DNA was sheared into 400–600-base pair frag-
ments by focused ultrasonication (Covaris Adaptive
Focused Acoustics technology, AFA Inc., Woburn, USA)
and standard Illumina libraries were prepared. 100 base
pair paired end reads were generated on the HiSeq 2000
according to the manufacturer’s standard sequencing proto-
col (Bonner et al., 2009) to produce an average of 55.4-fold
read coverage per site with at least 21-fold median depth
for each sample (Supporting Information Table S1). ENA
SRA accession numbers for all sequencing libraries are
listed in Table S1. The DNA reads were screened for con-
tamination, PCR duplicate were removed, and those with
insert sizes<1,000 bases were mapped using Smalt with
exhaustive alignments (version 0.7.2 www.sanger.ac.uk/
resources/software/smalt/, Ponstingl and Ning, 2010). Non-
mapping reads, low quality bases, bases in repetitive
regions, bases with poor mapping scores, bases in low-
complexity regions and bases with low read coverage were
all excluded from analysis. Bases with significant forward-
reverse strand amplification bias were a result of reads
mapping mainly to a single DNA strand and though rare
were eliminated by determining the rate of variants as a
function of this strand bias effect.
We scanned for dose-dependent, heterozygous and
homozygous mutations because these may be haplosuffi-
cient, and proteins associated with resistance may form
heterodi- or multi-mers (Paape and Aebischer, 2011). Chro-
mosome copy number variation and scans for large CNVs
and episomes were performed based on per cell read depth
to reflect gene dosage as outlined previously (Downing
et al., 2011). Using the difference in read-depth allele fre-
quencies between steps, 53% of valid SNPs were homozy-
gous (a read-depth frequency>0.95). This approach
detected heterozygous alleles on trisomic and tetrasomic
chromosomes where differences in the allele frequencies
based on the reads can be more challenging to detect if
present on a single chromosome only. Multiple complemen-
tary variant-calling tools were used to discover SNPs and
infer genotypes: Samtools pileup v0.1.11 (Li et al., 2009),
Samtools mpileup v0.1.18, FreeBayes (Garrison and Marth,
2012), GATK (McKenna et al., 2010) and Cortex (Iqbal
et al., 2012). SNPs associated with 74 mM MIL resistance
were present in all technical replicates.
Candidate MIL-R mutations were identified using a deep
sequencing approach using promastigote parasites from
each selection step after cloning of the parental parasite,
that is, after adaption to 3, 6, 12, 35, 49, 61and 74 mM MIL.
Four (Sb-S MIL-R clone 8) and six (Sb-R MIL-R clone 9)
replicates were sequenced to verify the mutations present
in the MIL-R parasites. We also determined the effect of
removing drug pressure on the genotype of the Sb-S and
Sb-R MIL-R cloned parasites, by maintaining them for two
weeks without drug pressure (741 0 mM MIL). WT para-
sites with the same passage number were sequenced at
the same time as the corresponding MIL-R parasites to
ensure that polymorphisms associated with long-term pas-
saging were omitted from drug association. Chromosome
copy number (somy), local gene copy number variation
(CNV) including extra-chromosomal segments such as epi-
somes, single nucleotide polymorphisms (SNPs) and indels
were examined at each experimental stage. Mutations alter-
ing the amino acid code are more likely to have a pro-
nounced positive or negative effect on protein function, and
changes unique to the MIL-resistant clones must be either
beneficial or neutral (Weinreich et al., 2006). Consequently,
nonsynonymous mutations distinguishing MIL-R from WT
consistent across each step of the selection processes
were more likely to be truly implicated in MIL resistance.
Statistical inference of the selective benefit of resistance
mutations
A likelihood framework was used to evaluate the mean role
of selection acting upon genetic variants within the popula-
tion (Illingworth and Mustonen, 2012), including both muta-
tion frequencies and somy variants. Given a set of
observed data O, parameters within a variety of models M
were optimized to maximize the likelihood L(O|M). Different
models described different patterns of evolution under neu-
trality, or selection for specific genetic variants. The Bayes-
ian Information Criterion (BIC) was used to distinguish
between models of differing complexity, minimising the
value:
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BIC 5 22 log L OjMð Þ 1 k log n
where n is the number of data points in the model and k is
the number of model parameters. Observed allele frequen-
cies were modelled using a multinomial likelihood function,
while observed changes in chromosomal copy number
were modelled using a double Poisson likelihood function.
Full details of the model are given in Supporting Information
Text S4.
Prediction of protein mutation amino acid properties,
position and functional impact
The biochemical and structural properties of proteins were
examined using amino acid hydrophobicity to determine the
TM portions of the protein using Bioedit v7.0.9.1, ProtScale
(Gasteiger et al., 2005) and the Membrane Protein Explorer
(MPEx v3.2, Snider et al., 2009). Surface accessibility and
secondary structure were used to predict whether mutant
amino acids were more likely to be internal or external in
the protein, and if they were part of alpha-helix, beta-sheet
or coil structures (NetSurfP, Petersen et al., 2009). Protein
function impacts were predicted with Polyphen-2 v2.2.2
(Adzhubei et al., 2010), SNAP (Bromberg and Rost, 2007)
and SIFT (Kumar et al., 2009).
PCR studies
PCR studies were completed using genomic DNA or cDNA
prepared from RNA, both isolated using L. donovani pro-
mastigotes. Genomic DNA was prepared using the DNeasy
Blood & Tissue kit and RNA was isolated using the RNeasy
Mini Kit. Complementary DNA was synthesized from 2 mg
of RNA, using 1 ml of Random Primers diluted with molecu-
lar grade water to give final volume of 15 ml. The mixture
was incubated at 658C for 5 min and samples were then
left at room temperature for 10 min before adding 2 ml of
10X Affinity script buffer, 2ml of 100 mM DDT, 0.8ml of
100mM deoxynucleotide triphosphate (dNTP) mix and 1ml
of RT enzyme to a final volume of 20 ml. Samples were
incubated at 258C for 10 min, followed by 558C for 1 hour,
and then heated at 708C for 15 min. PCR studies with pri-
mers specific for L. donovani LdMT gene (LdMT-Forward:
50-CAAGTGCCTTTCCACCAGAATC-30,LdMT-Reverese: 50-
CTCACCTTTTTGAACTCCAAC AGG-3) and alpha-tubulin
gene (AlphaTubulin-Forward: 50-AGCTGTCCGTCGCGGACA
TCA CGAACTCGGTGTTT-30, AlphaTubulin-Reverse:50-CGAA
CTGAATTGTGCGCTTCGTCT TGATCGTCGCAAT-3’). Each
PCR reaction contained 2 ml of MyTaq DNA Polymerase, 10
ml of 5x Reaction Buffer, 25 of pmol each of forward and
reverse primers, 2 ml of DNA and made to a final volume of
30 ml with molecular grade water. PCR conditions were as fol-
lows: Denaturation at 948C for 3 min, 35 cycles of 948C for
30 sec, annealing 648C for 45 sec and extension at 728C for
1 min. Final extension was carried out at 728C for 10 min.
PCR products were separated by gel electrophoresis and the
products visualized under UV light and a digital image of the
results obtained.
Quantitative RT-PCR reactions were carried out in a final
volume of 12.5 ml, using 6.25ml of SYBR green, 1 ml of tem-
plate cDNA, 25 of pmol of forward and reverse primers (as
above) and molecular grade water. In RT-PCR reactions the
following conditions were used: denaturation at 958C for 10
min; 40 cycles of the following steps: 958C for 30 sec, 638C
for 45 sec and extension at 728C for 1 min; and a final
cycle of 958C for 30 sec and 558C for 30 sec. All samples
were carried out in duplicate. Gene expression was calcu-
lated using the 2DDCT method (Livak and Schmittgen, 2001)
method. The housekeeping gene a-tubulin was used as a
comparison for expression levels.
Promastigote inhibition studies
The effects of MIL on the growth of promastigotes were
tested using a colorimetric-based assay using resazurin.
Parasites were added to the wells of a 96 well tissue cul-
ture plate at a concentration of 5 3 105 parasites/well and
grown in the presence of medium alone (controls) or
medium containing various concentrations of MIL (3–785
lM, n5 6/treatment). Plates were incubated for 72 hours at
278C. and then 20 ml of resazurin solution (0.0125% w/v
PBS pH 7.4) was then added to samples and the samples
were incubated for a further 18 hours at 278C. The absorb-
ance of samples at 550–590 nm was determined using
Softmax Pro 2.0 software. The effect of drug treatment on
cell viability was determined by calculating the percentage
suppression in cell growth for drug treated samples com-
pared with the mean control value (n5 6/treatment). The
mean suppression/treatment was used to determine the
IC50 for a particular formulation using Grafit
VR
5 software.
MIL uptake studies
To quantify the uptake of MIL by WT and MIL-R parasites,
5 ml cultures of parasites at day 4 of growth were pelleted,
resuspended in 5 ml medium containing 7 mM of MIL, and
the resulting suspension was transferred to a new tissue
culture flask. Flasks were quenched at time 0, 30, 60 and
120 min post exposure to MIL and 4 3 107 parasites were
aliquoted into pre-chilled eppendorfs, sitting on ice. Lipid
extraction was then carried out on these samples as
described above. A calibration curve was produced by spik-
ing samples of the extraction solvent with MIL standards at
0.24, 0.72, 2.4, 7.2 and 14.4 mM. Linear regression was
used to fit a standard curve for the AUC of the MIL peak
from the standards (correlation coefficent> 0.97), and this
data was used to determine the MIL present in parasites at
time of quenching.
Macrophage studies
Peritoneal macrophages, harvested from mice 72 hours
after intraperitoneal injection of starch solution (3% w/v
PBS pH 7.4), using the method described by Carter et al.
(2005). Cells were infected using a host: parasite ratio of
20:1. The effect of treatment on parasite survival was deter-
mined as the mean percentage suppression in the percent-
age of cells infected and the number of parasites/host cell/
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for each treatment (n54/treatment) by comparing each
experimental value with the relevant mean control value.
Statistical analysis of data
The effect of drug treatment on cell proliferation in in vitro
drug studies were analyzed using a Mann Whitney U test
for comparing two treatments or a Kruskal Wallis test fol-
lowed by Dunns ad hoc test for statistical differences
between three or more treatments (Statview
VR
v5.0.1). Lipi-
domic and metabolomic data which compared WT with WT
or WT with the corresponding MIL-R were analyzed using a
Mann Whitney U-test or a Student’s t-test where the P-val-
ues were corrected for multiple testing using the Benjamini-
Hochberg method using R. The null hypothesis was not
accepted if the adjusted P<0.05.
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